What is NewDays?
NewDays is an AI-driven company dedicated to transforming cognitive health treatment. The company provides accessible telehealth appointments with specialized cognitive clinicians, complemented by personalized brain exercise homework. This is facilitated by an AI companion named Sunny, designed to guide users through their recovery and cognitive enhancement journey. NewDays aims to bridge the gap in mental wellness by leveraging artificial intelligence for scalable and effective cognitive care.
How much funding has NewDays raised?
NewDays has raised a total of $7M across 1 funding round:
Seed
$7M
Seed (2025): $7M with participation from Madrona Venture Group and General Catalyst
Key Investors in NewDays
Madrona Venture Group
Madrona Venture Group, established in 1995, is a venture capital firm with a focus on consumer internet, commercial software, and services.
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across various sectors and stages, focusing on ambitious entrepreneurs and management teams. They provide strategic capital and operational support to accelerate growth and build enduring enterprises.
What's next for NewDays?
With this substantial enterprise-level backing, NewDays is poised for significant expansion and further development of its AI-powered cognitive health platform. The recent strategic investment will likely fuel advancements in its technology, enhance its service offerings, and broaden its market reach. The company is expected to scale its operations, potentially increasing its clinician network and refining the AI companion's capabilities to offer even more personalized and effective cognitive interventions. This funding round signals a strong belief in NewDays' potential to disrupt the cognitive health sector through innovative technology and accessible care solutions.
See full NewDays company page
